Shanghai MicroPort MedBot (Group) Co., Ltd. (2252.HK)

13.300 +0.400 (+3.10%) At close: 04:08PM HKT

Shanghai MicroPort MedBot (Group) Co., Ltd.

Building 1
Room 101, Area B 1601 Zhangdong Road China (Shanghai) Pilot Free Trade Zone
Shanghai
China
86 21 3895 4600
https://www.medbotsurgical.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 646

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Chao He	President & Executive Director	2.75M	N/A	1986
Ms. Xiaoyu Cui	Financial Controller	N/A	N/A	1980
Mr. Yu Liu	Executive VP & Chief Commercial Officer	N/A	N/A	1970
Ms. Cong Fang	Board Secretary	N/A	N/A	1990
Ms. Yin Shan Hui A.C.I.S., A.C.S., HKICS, ICSA	Company Secretary	N/A	N/A	1969

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People's Republic of China. It offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot for coronary angioplasty; and iSR'obot, a Mona Lisa robotic transperineal prostate biopsy system. The company also provides spine surgical robots for spine surgery; trans-bronchial surgical robots for trans-bronchial diagnosis and treatment; TAVR surgical robots for heart valve replacement surgery; and thoracic and abdominal puncture surgical robot for percutaneous lung biopsy and percutaneous liver biopsy. In addition, it manufactures parts of surgical robot devices; engages in assembly and distribution of surgical robot devices; research and development of system, as well as investment activities. Shanghai MicroPort MedBot (Group) Co., Ltd. was founded in 2014 and is based in Shanghai, China. Shanghai MicroPort MedBot (Group) Co., Ltd. operates as a subsidiary of Shanghai Latent Artificial Intelligence Co., Ltd.

Corporate governance

Shanghai MicroPort MedBot (Group) Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.